FDA staff sends mixed message on JJ drug Xarelto
WASHINGTON (Reuters) - U.S. drug reviewers had mixed opinions about whether Johnson Johnson blood thinner Xarelto reduced the risk of new heart attacks and strokes in people with heart problems, setting the stage for heated debate by outside experts later this week. (Source: Reuters: Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div

Secret Clinics Tend to Bahrain’s Wounded
Amid an uprising, “no one goes to the hospital,” one protester said. The police are there. (Source: NYT Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div